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Abstract
Background:  Elective endotracheal intubations are still commonly performed without
premedication in many institutions. The hypothesis tested in this study was that morphine given
prior to elective intubations in neonates would decrease fluctuations in vital signs, shorten the
duration of intubation and reduce the number of attempts.
Methods: From December 1999 to September 2000, infants of all gestations admitted to a level
III neonatal intensive care unit and requiring an elective endotracheal intubation were randomly
assigned to receive morphine 0.2 mg/kg IV or placebo 5 minutes before intubation. Duration of
severe hypoxemia (HR< 90/min and Sp02<85%), duration of procedure, duration of hypoxemia
(Sp02<85%), number of attempts and change in mean blood pressure were compared between
groups.
Results: 34 infants (median 989 g and 28 weeks gestation) were included. The duration of severe
hypoxemia was similar between groups. Duration of procedure, duration of hypoxemia, number of
attempts and increases in mean blood pressure were also similar between groups. 94% of infants
experienced bradycardia during the procedure.
Conclusion: We failed to demonstrate the effectiveness of morphine in reducing the physiological
instability or time needed to perform elective intubations. Alternatives, perhaps with more rapid
onset of action, should be considered.
Background
Endotracheal intubation is a painful and stressful proce-
dure, which is associated with acute increases in blood
pressure and intracranial pressure, bradycardia and
hypoxemia [1]. These physiologic changes are potentially
of sufficient magnitude to produce the reperfusion injury
and venous congestion associated with intraventricular
hemorrhage (IVH) and periventricular leukomalacia
(PVL) [2,3]. It has been clearly demonstrated that new-
born infants feel pain. More so, premature infants likely
have an increased sensitivity to pain [4], which can lead to
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chronic pain or neurobehavioral and developmental
sequelae [5,6].
Most premature infants and many term infants admitted
to neonatal intensive care units (NICU) will require one
or more endotracheal intubations during their stay. In
1994, 84% of Canadian NICUs, including ours, rarely or
never used premedication for elective intubations [7]. In
2000, the majority of units used premedication 50–75%
of the time in infants greater than 30 weeks gestation, but
only rarely in those 30 weeks gestation or less [8]. Per-
ceived lack of evidence of benefits and fear of side effects
were reasons.
A literature review revealed six randomized controlled tri-
als [9-14], comparing various combinations of premedi-
cations, which have enrolled one hundred and thirty
newborn infants. Bradycardia can be ameliorated by atro-
pine [9,10] or glycopyrrolate [11]. Increases in intracra-
nial pressure can be dampened by muscle relaxants [9-
12]. Analgesics, which seem warranted, have been mini-
mally studied alone [13], but seem to limit the increase in
blood pressure when combined with muscle relaxants
[11]. A recent metaanalysis concludes that overall, pre-
medication appears beneficial, either in stabilizing vital
signs or decreasing the duration of the procedure, but data
is limited about which medications are best to achieve
optimal conditions [15].
We reviewed our policy, which did not include premedi-
cation for elective endotracheal intubations, in light of the
current evidence. As morphine has been used for years in
neonates with apparent safety and efficacy for pain and as
staff in our unit were comfortable with this medication,
we aimed to evaluate the efficacy of morphine, in achiev-
ing better intubation conditions and success while main-
taining vital signs stability.
Methods
Study population
Infants of all gestations, admitted to McMaster University
Medical Center level III NICU and considered likely to
need an elective oral or nasotracheal intubation during
their hospital stay, were candidates for inclusion in this
study. Families were approached for consent as soon as
possible after birth when an elective intubation during
their hospital stay seemed likely: if their infant(s) was less
than 30 weeks gestation, already ventilated (as endotra-
cheal tubes are frequently changed after 10 days if clinical
deterioration from a respiratory standpoint), was on
NCPAP for respiratory distress or was needing an elective
surgery. Others were approached when an elective intuba-
tion was needed. At the time of this study, our unit was a
33-bed level 3 NICU, caring for both inborn and outborn
patients, and the referral center for 25000 annual deliver-
ies, with 900–1000 admissions per year.
Infants were excluded if they met any of the following
conditions: 1) absence of an intravenous access, 2) upper
airway anomaly potentially leading to a difficult intuba-
tion, 3) cyanotic heart disease, 4) upper gastrointestinal
obstruction (which would require a rapid sequence intu-
bation) or 5) concurrent opioid administration.
Study intervention
Infants requiring an elective intubation were randomly
assigned to receive either morphine 0.2 mg/kg IV or pla-
cebo (0.9% NaCl), given over 1 minute, followed 5 min-
utes later by the intubation. This larger dose of morphine
was chosen for the perceived acuity of pain produced by
an intubation; a larger dose may be more effective to
decrease the struggling by infants during the procedure,
which is caused by pain. Infants were randomized accord-
ing to a computer-generated random number table with
random block sizes. Morphine and placebo were supplied
in identical unidose vials, labeled PIN Rx, which were pre-
pared by one pharmacist according to the randomization
sequence and placed in sealed, consecutively numbered
envelopes, which were opened just before intubation.
Thus, randomization occurred just prior to intubation.
Three to four minutes after receiving the study medica-
tion, infants were preoxygenated with 100% 02 and hand-
ventilated with a self-inflatable bag for 1–2 minutes prior
to intubation. Infants having their endotracheal tube
replaced were ventilated through their existing tube until
it was removed. Vital signs (HR, BP, Sp02) were captured
to a laptop computer from the infant's monitor (PC
Express, Spacelabs Inc., Redmond WA) every 5 seconds
(except blood pressure which was obtained with a self
inflating cuff every minute) using Procom Plus Commu-
nication Software, from the time the study medication
was given (which was considered the baseline) to 5 min-
utes after the infant's vital signs returned to pre-procedure
values. One of three investigators, not involved in the pro-
cedure collected the following data manually: duration of
the procedure (defined as the time between insertion of
the laryngoscope in the mouth to confirmation of
endotracheal tube placement by auscultation) and the
number of intubation attempts (defined as number of
times the laryngoscope was inserted in the mouth). If
there was more than one attempt, the clock continued
between attempts and was stopped only when tube place-
ment was confirmed by auscultation. In our NICU, the
preferred method of intubation is via the nasotracheal
route if mechanical ventilation is expected for more than
a few hours.BMC Pediatrics 2004, 4:20 http://www.biomedcentral.com/1471-2431/4/20
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All team members performed the intubations: staff
neonatologists a, neonatal fellows b, pediatric residents c,
clinical nurse specialists d, clinical nurse specialist stu-
dents  e  and transport nurses f. After 2 unsuccessful
attempts by a junior team member (c,d,e,f), a more expe-
rienced intubator (a,b) was called.
Institutional ethics committee approval and informed
consent from the parents were obtained for this study.
Outcome measures
The study aimed to test the hypothesis that morphine 0.2
mg/kg would decrease fluctuations in vital signs, shorten
the duration of the procedure and reduce the number of
attempts. The primary outcome was the duration of severe
hypoxemia, defined as Sp02 < 85% with a HR< 90/min.
This was felt to be the most undesirable side effect of
endotracheal intubation as cerebral blood flow in
neonates is highly dependent upon heart rate. Secondary
outcomes included: (1) duration of the procedure, (2)
duration of hypoxemia (Sp02 < 85%), (3) number of
attempts, (4) maximum change in blood pressure from
baseline, (5) occurrence of bradycardia (HR<90/min).
Sample size
The study group's impression was that a majority of
infants experience some degree of severe hypoxemia dur-
ing an elective intubation, which was clinically undesira-
ble. It was estimated to be 30 seconds, based on
experience. In order to detect a one standard deviation dif-
ference in duration of severe hypoxemia between the 2
groups (α = 0.05, 2-sided, β = 0.2), 17 patients per group
were required.
Statistical analysis
Because the distribution of the main outcome was skewed
and groups were small, continuous variables were com-
pared using the Mann-Whitney U test. Dichotomous var-
iables were compared using Fisher's exact test or Chi-
square test. A p value < 0.05 (2-sided) was considered sig-
nificant for the primary outcome; p < 0.01 was considered
significant for secondary outcomes to account for multi-
ple analyses in a small sample. Level of experience of the
intubator, birth weight and gestational age were sepa-
rately explored as potential confounders of the primary
outcome using ANOVA or linear regression.
Results
Patients were recruited from December 1999 to Septem-
ber 2000. Patient flow in the study is depicted in figure 1.
Two hundred and fifteen infants were identified as poten-
tial candidates for the study. Ninety-nine of them never
required an elective intubation but 35 did, they were
missed, as parents or investigators were not available at
the time. Eighty-one families were approached for con-
sent. Consent was obtained for 64 infants of whom 34
were enrolled and randomized. Thirty were not rand-
omized: 13 never required an intubation and 17 elective
intubations were missed, mainly because they happened
at night, when investigators were not on site. Missed
patients had similar gestation, birth weight and reason for
intubation as those enrolled. All patients randomized
received the intervention and data from all randomized
patients were analyzed. Physiological stability was main-
tained in all infants, between the time the study drug was
given, to the time the endotracheal intubation was
performed.
Baseline characteristics are presented in Table 1. Both
groups had similar birth weight, gestation, and baseline
vital signs. Importantly, the number of primary intuba-
tions/failed extubation and changes of endotracheal tube
(which is usually considered easier) were similar between
groups. All intubations were nasotracheal. Results of the
primary and secondary outcomes analysis are presented in
Table 2. Only 8/17 infants in the treatment group and 7/
17 in the control group experienced some degree of severe
hypoxemia. The median duration of severe hypoxemia
was similar between groups. An outlier (severe hypoxemia
lasting for 300 seconds) was identified in the treatment
group. Considering the small number of patients, this
outlier was taken out and the data reanalyzed, but this did
not change the results significantly. The level of experi-
ence of the intubator, birth weight and gestation were
entered separately in a regression model, but none was a
significant contributor to the variance of the results.
Flow of patients at each stage of the study Figure 1
Flow of patients at each stage of the studyBMC Pediatrics 2004, 4:20 http://www.biomedcentral.com/1471-2431/4/20
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All patients in the treatment group and 14/17 in the con-
trol group experienced hypoxemia (Sp02 < 85%) during
intubation. The median duration of hypoxemia was 235
sec in the treatment group and 90 sec in the control group
(p = 0.04). Because of our small sample and the likeli-
hood of finding a significant result by chance alone when
assessing multiple outcomes, it was decided a priori that a
p value of 0.01 would be considered significant for sec-
ondary outcomes. Nevertheless, this represents an inter-
esting but somewhat worrisome trend. No difference was
found in the maximal increase in blood pressure. Ninety-
four percent of patients experienced bradycardia (HR<90/
min) during the procedure with no difference between
groups.
The median duration of the procedure was 271 sec in the
treatment group and 94 sec in the control, which was not
statistically significant. Roughly half of the infants
required more than one attempt to achieve successful
intubation and the clock was not stopped between
attempts. Number of attempts in the treatment group
(median 2), was similar to controls (median 1); total
number of attempts was 38 in the premedicated infants
versus 31 in the controls. Success rate at first attempt or
need to call a more senior intubator after 2 failed attempts
did not differ between groups. Because of the higher than
usual dose of morphine that was used, we monitored the
need to increase ventilator support over the next 24 h, in
infants having their tubes changed, but found no differ-
ence between groups.
Discussion
Newborn infants, especially premature ones have adverse
physiological responses to routine care procedures [2,4].
Endotracheal intubation is a stressful procedure, associ-
ated with physiologic instability [9-14]. Our data also
show this instability, with 94% of infants experiencing
bradycardia and the mean blood pressure increasing by as
much as 46%.
Our hypothesis was that a moderate dose of morphine
would facilitate intubation and stabilize vital signs better
than placebo. Our data does not support this hypothesis.
No significant difference was identified between the treat-
ment and the control group in any prespecified outcome.
The choice of severe hypoxemia as the primary outcome,
Table 1: Baseline characteristics of included patients *Values expressed as medians (interquartile range)
Morphine group n = 17 Control group n = 17
Birth weight, grams* 1065 (731.5, 2043) 904 (689, 1535.5)
Gestation, weeks* 28 (26, 33) 27 (26, 30)
Gender male/female, n 11/6 9/8
Age at randomization, days* 3 (0.61, 16) 8 (0.63, 13)
Primary intubation/failed extubation, n 7 7
Change of endotracheal tube, n 10 10
Baseline HR, bpm* 152 (142.5, 157.5) 161 (151.5, 166.5)
Baseline Sp02, %* 94 (92.5, 95) 94 (92.5, 98)
Baseline BP, mm Hg* 38.5 (35.25, 44.75) 37.5 (33.25, 44.5)
Baseline fi02, %* 40 (27, 45) 32 (25, 41.25)
Experienced intubator, n 9 7
Junior intubator, n 8 10
Table 2: Primary and secondary outcomes results *Values expressed as medians and interquartile range
Morphine group Control group p value
Duration of severe hypoxemia, seconds* 10 (0, 62.5) 5 (0, 45) 0.45
Duration of hypoxemia, seconds* 235 (82.5, 340) 90 (20, 187.5) 0.04
Duration of procedure, seconds* 271 (57.5, 418.5) 94 (62, 215.5) 0.27
Maximum increase in mean BP from baseline, mm Hg* 18 (9, 24.25) 20 (11.75, 28) 0.65
Number of attempts, n* 2 (1, 3.5) 1 (1, 2.5) 0.34
Intubation achieved at first attempt, n 7 9 0.49
Intubation needing rescue intubator, n 7 4 0.27
Bradycardia during procedure, n 16 12 0.175BMC Pediatrics 2004, 4:20 http://www.biomedcentral.com/1471-2431/4/20
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although clinically very important, significantly limited
the number of observations and increased the possibility
of a type 2 error, as few infants met the criteria defining
this outcome. The onset of action of morphine is about 5
minutes in infants, but the peak action occurs only at 15
to 30 minutes [16], perhaps too long for a procedure such
as an intubation, as it does not lead to sufficient relaxation
to permit adequate airway visualization. Although there
was no formal assessment of the level of sedation of our
infants done, bedside nurses reported not being able to
discriminate between groups 5 minutes after injection of
the study drug.
The only trend we identified was the duration of hypox-
emia, which appeared longer in the treatment group. Most
desaturations were in the mid 70's to low 80's range, but
this is still a worrisome finding. We were unable to iden-
tify if birth weight, gestation or experience level of the
intubator were significant contributors. Our sample size
likely did not permit to identify such a contributor.
Although morphine may not be potent enough to
significantly relax infants to permit quicker and easier
intubations, it may lead to decreased functional residual
capacity in partially sedated infants, which could account
for prolonged desaturations. The hypoxemia could have
been compounded by the use of self-inflating bag and
masks, which cannot provide a positive end-expiratory
pressure (PEEP). Also, the larger dose of morphine used in
this study could have contributed to this potential prob-
lem, by further decreasing the FRC in partially sedated
infants. This trend is in keeping with the finding that,
although not statistically significant, median duration of
the procedure was 3 times as long in the treatment group
as in the controls.
Ninety four percent of infants experienced bradycardia,
mostly vagal, during their intubation. As cerebral blood
flow in infants is greatly dependent on heart rate, our data
adds to the current knowledge that including atropine in
the premedication appears warranted. Although there
may be concern that atropine could mask hypoxia-
induced bradycardia, the now universal use of oxygen sat-
uration monitors should ensure that hypoxemia is
identified.
Previous trials have used various combinations of drugs
for premedication and overall, they suggest that premedi-
cation is effective and safe. Kelly [9] and Barrington [10],
using atropine and a muscle relaxant, demonstrated a
reduction in vagal bradycardia and a dampening in the
rise in intracranial pressure. The use of a muscle relaxant
without an analgesic would now be considered unaccept-
able practice. Friesen [12] compared atropine alone to
atropine and a non-standardized anesthetic and pancuro-
nium in stable term infants preoperatively. The treatment
group had less increase in intracranial pressure. This study
included only stable infants. Pokela [11] compared 10
infants randomly allocated to glycopyrrolate and pethi-
dine to 10 infants who received glycopyrrolate, alfentanil
and suxamethonium. The addition of a muscle relaxant
decreased both the duration of hypoxemia and the dura-
tion of the procedure by half. Only experienced physi-
cians performed the intubations, which limits
generalizability. The durations of procedure and hypox-
emia in our morphine group were similar to their pethi-
dine group. Buthada [13] compared thiopenthal in
anesthetic doses to placebo in infants over 2 kg. Intuba-
tions were shorter and heart rate and blood pressure were
more stable in the treatment group. Oei [14] compared
morphine, atropine and suxamethonium to awake intu-
bations in 20 infants. Interestingly, even when residents
with little or no neonatal experience performed the intu-
bation, the duration of the procedure was significantly
shorter and the number of attempts halved in the premed-
icated group. Barrington [17] used atropine, fentanyl and
succinylcholine in 269 consecutive intubations and
reported no major complication; no data was available on
duration of procedure or vital signs stability. Few very
small infants were enrolled in these trials and most used a
combination of premedication, which makes comparison
with our trial difficult.
Our study has several limitations. First, our sample size is
relatively small, which precludes us from eliminating a
type 2 error. We began this project with the assumption
that severe hypoxemia would occur for about 30 seconds,
which was not the case. An observational study would
have been useful before making this assumption.
Although limited in size, results of this trial should be use-
ful for future investigators and clinicians in their choice of
premedication. Second, due to limited resources
(unfunded trial), as this study was planned as a pilot, to
assess feasibility and adequacy of equipment to obtain
data, we decided not to stratify for gestational age. This
could have been very useful in refining the findings, as
more immature infants may respond differently to pre-
medication in general and have less strength to struggle
during an unpremedicated or not sufficiently premedi-
cated painful procedure. Third, as we wanted to mimic
our actual NICU practices, in view of modifying such prac-
tices, we did not restrict the study intubations to very
experienced operators. As a result, there was substantial
variability in the level of experience between individuals.
Given our small number of patients, this might have
impacted on the outcomes. Fourth, several eligible infants
were not enrolled. This was due to unavailability of either
trial investigators or parents, as many intubations
occurred at night. The infants enrolled and those not
enrolled had similar birth weights, gestation and reasonBMC Pediatrics 2004, 4:20 http://www.biomedcentral.com/1471-2431/4/20
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for intubation, which is reassuring, but does not eliminate
the potential for enrolment bias.
Conclusions
Infants are entitled to effective pain management strate-
gies [18]. It seems only humane to premedicate infants
when possible, for known stressful and painful proce-
dures, as we would for older children and adults. Overall,
our findings suggest that morphine probably is not the
analgesic of choice or insufficient on its own for elective
endotracheal intubations. A more rapid onset analgesic
like remifentanil, along with atropine should be evaluated
and the role of muscle relaxants needs to be better
defined. Infants should be stratified either by gestational
age or birth weight, to capture differences in their
response to premedication and to intubation. Objective
measures of pain like the Premature Infant Pain Profile
(PIPP) score [19] and/or endocrine indicators of stress
should be included in outcomes, which should remain
focused primarily on the short-term comfort of the infants
but also their safety. Long-term physiologic and clinical
outcomes should be incorporated into the trial design.
Consideration should be given to including various levels
of experience of intubators to increase generalizability
and applicability of the findings to units where residents
and other allied health professionals are trained to intu-
bated infants.
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